Cancer Treatment for about $1.30 a Share
May 22nd, 2006 | By Greg Guenthner | Category: Investing Strategies, Penny stocks, Technology
Back in March, I wrote to you about the drug company Genta (GNTA: NASDAQ). The company is developing a drug called Genasense that is currently being reviewed by the FDA.
Genasense is a drug given to cancer patients to assist chemotherapy. It is an anti-sense treatment, which consists of chemically modified ...read more
